Needham & Company Downgrades Endo Pharmaceuticals Holdings Inc (ENDP) to Underperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Endo (ENDP) Slides as CEO 'Transition Plan' Includes CEO Retiring...and Nothing Else
December 12, 2012 5:33 PM ESTEndo Pharmaceuticals Holdings (NASDAQ: ENDP) shares are lower in late trading following announcement of a "CEO Transition Plan."
Here's the plan:
1. CEO David P. Holveck is retiring;
2. That's all.
Endo said it wouldn't conduct a search,... More
Endo Health (ENDP) in Search of CEO
December 12, 2012 5:27 PM ESTEndo Health Solutions Inc. (Nasdaq: ENDP) announced today David P. Holveck, 67, President and Chief Executive Officer, will retire in 2013. He will continue to serve in his present positions until the earlier of his successor being in place or the May 2013 annual meeting of Endo... More
